Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00900406 · ClinicalTrials.gov registry record
Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant
A clinical trial, sponsored by Vanderbilt-Ingram Cancer Center.
- Completed
- Registry status
- 190
- Enrollment target
NCT00900406: Completed study, sponsored by Vanderbilt-Ingram Cancer Center.
NCT00900406 is a clinical trial that has completed, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 190 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00900406 has completed, sponsored by Vanderbilt-Ingram Cancer Center.
- COMPLETED
- Registry status
- 190 participants
- Enrollment target
Study Summary
RATIONALE: Collecting and storing samples of blood, urine, and tissue from patients undergoing a donor stem cell transplant to test in the laboratory may help the study of graft-versus-host disease in the future. PURPOSE: This research study is collecting and storing tissue and DNA samples from patients undergoing a donor stem cell transplant.
Interventions
- GENETIC gene expression analysis
- GENETIC microarray analysis
- OTHER flow cytometry
- GENETIC polymorphism analysis
- GENETIC proteomic profiling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2007-01 |
| Est. Completion | 2010-03 |
What the finished NCT00900406 record still lists
NCT00900406 is an observational study that tracks outcomes without assigning an intervention. The registered 190 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 5 interventions - of which gene expression analysis is the first listed.
NCT00900406 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00900406 about?
NCT00900406 is a clinical study titled "Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant". RATIONALE: Collecting and storing samples of blood, urine, and tissue from patients undergoing a donor stem cell transplant to test in the laboratory may help the study of graft-versus-host disease in the future. PURPOSE: This research study is collecting and storing tissue and DNA samples from pat...
What is the current status of trial NCT00900406?
This trial is currently completed. The enrollment target is 190 participants. The study started on 2007-01. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00900406?
The interventions under investigation include: gene expression analysis (GENETIC), microarray analysis (GENETIC), flow cytometry (OTHER), polymorphism analysis (GENETIC), proteomic profiling (GENETIC).
Who is sponsoring clinical trial NCT00900406?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03257033 · 190 participants · Phase 3
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
- NCT03642028 · 190 participants · Phase 4
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
- NCT04015609 · 190 participants · NA
Psychotherapy Intervention for Latinos With Advanced Cancer
- NCT04284397 · 190 participants · Early Phase 1
Identification of Critical Thermal Environments for Aged Adults
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia